Australia - English - Department of Health (Therapeutic Goods Administration)

lundbeck australia pty ltd - vortioxetine hydrobromide, quantity: 6.355 mg (equivalent: vortioxetine, qty 5 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; hyprolose; sodium starch glycollate type a; mannitol; titanium dioxide; hypromellose; iron oxide red; macrogol 400 - treatment of major depressive disorder in adults including prevention of relapse. vortioxetine is not indicated for paediatric use.

Australia - English - Department of Health (Therapeutic Goods Administration)

lundbeck australia pty ltd - vortioxetine hydrobromide, quantity: 19.065 mg (equivalent: vortioxetine, qty 15 mg) - tablet, film coated - excipient ingredients: magnesium stearate; mannitol; sodium starch glycollate type a; hyprolose; microcrystalline cellulose; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; macrogol 400 - treatment of major depressive disorder in adults including prevention of relapse. vortioxetine is not indicated for paediatric use.

Australia - English - Department of Health (Therapeutic Goods Administration)

lundbeck australia pty ltd - vortioxetine hydrobromide, quantity: 25.42 mg (equivalent: vortioxetine, qty 20 mg) - tablet, film coated - excipient ingredients: sodium starch glycollate type a; magnesium stearate; hyprolose; microcrystalline cellulose; mannitol; titanium dioxide; hypromellose; iron oxide red; macrogol 400 - treatment of major depressive disorder in adults including prevention of relapse. vortioxetine is not indicated for paediatric use.

Australia - English - Department of Health (Therapeutic Goods Administration)

lundbeck australia pty ltd - vortioxetine hydrobromide, quantity: 12.71 mg (equivalent: vortioxetine, qty 10 mg) - tablet, film coated - excipient ingredients: mannitol; hyprolose; microcrystalline cellulose; magnesium stearate; sodium starch glycollate type a; titanium dioxide; hypromellose; iron oxide yellow; macrogol 400 - treatment of major depressive disorder in adults including prevention of relapse. vortioxetine is not indicated for paediatric use.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - citalopram hydrobromide, quantity: 49.98 mg (equivalent: citalopram, qty 40 mg) - tablet, film coated - excipient ingredients: glycerol; maize starch; microcrystalline cellulose; sodium starch glycollate; copovidone; purified talc; titanium dioxide; magnesium stearate; macrogol 6000; hypromellose; lactose monohydrate - treatment of major depression.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

pfizer ltd - linezolid - oral tablet - 600mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - linezolid - oral tablet - 600mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - linezolid - oral tablet - 600mg

Australia - English - Department of Health (Therapeutic Goods Administration)

avallon pharmaceuticals pty ltd - sertraline hydrochloride, quantity: 111.9 mg (equivalent: sertraline, qty 100 mg) - tablet, film coated - excipient ingredients: sodium starch glycollate; calcium hydrogen phosphate dihydrate; purified talc; hypromellose; magnesium stearate; microcrystalline cellulose; hyprolose; titanium dioxide - treatment of children (aged 6 years and older) and adolescents with obsessive compulsive disorder. treatment of major depression, obsessive compulsive disorder and panic disorder in adults.

Australia - English - Department of Health (Therapeutic Goods Administration)

avallon pharmaceuticals pty ltd - sertraline hydrochloride, quantity: 55.95 mg (equivalent: sertraline, qty 50 mg) - tablet, film coated - excipient ingredients: titanium dioxide; calcium hydrogen phosphate dihydrate; purified talc; microcrystalline cellulose; hypromellose; hyprolose; sodium starch glycollate; magnesium stearate - treatment of children (aged 6 years and older) and adolescents with obsessive compulsive disorder. treatment of major depression, obsessive compulsive disorder and panic disorder in adults.